BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10400756)

  • 1. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent.
    Srikiatkhachorn A; Chang W; Braciale TJ
    J Virol; 1999 Aug; 73(8):6590-7. PubMed ID: 10400756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.
    Varga SM; Wissinger EL; Braciale TJ
    J Immunol; 2000 Dec; 165(11):6487-95. PubMed ID: 11086089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
    Johnson TR; Johnson JE; Roberts SR; Wertz GW; Parker RA; Graham BS
    J Virol; 1998 Apr; 72(4):2871-80. PubMed ID: 9525607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.
    Tripp RA; Moore D; Jones L; Sullender W; Winter J; Anderson LJ
    J Virol; 1999 Sep; 73(9):7099-107. PubMed ID: 10438795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.
    Hancock GE; Tebbey PW; Scheuer CA; Pryharski KS; Heers KM; LaPierre NA
    J Med Virol; 2003 Jun; 70(2):301-8. PubMed ID: 12696122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against respiratory syncytial virus infection by DNA immunization.
    Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
    J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC; Hussell T; Openshaw PJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
    Johnson TR; Parker RA; Johnson JE; Graham BS
    J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
    Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
    J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
    Tripp RA; Hou S; Etchart N; Prinz A; Moore D; Winter J; Anderson LJ
    Cell Immunol; 2001 Jan; 207(1):59-71. PubMed ID: 11161454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IFN in respiratory syncytial virus pathogenesis.
    Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
    J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses.
    Simmons CP; Hussell T; Sparer T; Walzl G; Openshaw P; Dougan G
    J Immunol; 2001 Jan; 166(2):1106-13. PubMed ID: 11145691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
    Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
    J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
    Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
    J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.
    Johnson TR; Graham BS
    J Virol; 1999 Oct; 73(10):8485-95. PubMed ID: 10482601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.
    Sparer TE; Matthews S; Hussell T; Rae AJ; Garcia-Barreno B; Melero JA; Openshaw PJ
    J Exp Med; 1998 Jun; 187(11):1921-6. PubMed ID: 9607931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.
    Hussell T; Baldwin CJ; O'Garra A; Openshaw PJ
    Eur J Immunol; 1997 Dec; 27(12):3341-9. PubMed ID: 9464822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.